×
About 5,305 results

ALLMedicine™ Cholera Center

Research & Reviews  1,720 results

Vaccinomics to Design a Multi-Epitopes Vaccine for Acinetobacter baumannii.
https://doi.org/10.3390/ijerph19095568
International Journal of Environmental Research and Publi... Ud-Din M, Albutti A et. al.

May 15th, 2022 - Antibiotic resistance (AR) is the result of microbes' natural evolution to withstand the action of antibiotics used against them. AR is rising to a high level across the globe, and novel resistant strains are emerging and spreading very fast. Acin...

Cholera Outbreaks in India, 2011-2020: A Systematic Review.
https://doi.org/10.3390/ijerph19095738
International Journal of Environmental Research and Publi... Muzembo BA, Kitahara K et. al.

May 15th, 2022 - Fecal contamination of water sources and open defecation have been linked to cholera outbreaks in India. However, a systematic review on the drivers responsible for these outbreaks has yet to be published. Here, we systematically review the publis...

Cholera in the Time of MINUSTAH: Experiences of Community Members Affected by Cholera i...
https://doi.org/10.3390/ijerph19094974
International Journal of Environmental Research and Publi... Bartels SA, Fraulin G et. al.

May 15th, 2022 - In 2010, Haiti experienced one of the deadliest cholera outbreaks of the 21st century. United Nations (UN) peacekeepers are widely believed to have introduced cholera, and the UN has formally apologized to Haitians and accepted responsibility. The...

Mucosal-Associated Invariant T (MAIT) cells are highly activated in duodenal tissue of ...
https://doi.org/10.1371/journal.pntd.0010411
PLoS Neglected Tropical Diseases; Bhuiyan TR, Rahman MA et. al.

May 14th, 2022 - Mucosal-associated invariant T (MAIT) cells are unconventional T lymphocytes with a semi-conserved TCRα, activated by the presentation of vitamin B metabolites by the MHC-I related protein, MR1, and with diverse innate and adaptive effector functi...

Evaluating improved inactivated oral cholera vaccines for use in ending endemic cholera...
https://doi.org/10.1016/S1473-3099(22)00215-8
The Lancet. Infectious Diseases; Deen J, Holmgren J et. al.

May 10th, 2022 - Cholera causes substantial morbidity and mortality in the world's poorest populations. For nearly a decade, an inactivated oral cholera vaccine (OCV) stockpile has been available to control and prevent outbreaks. In 2017, WHO launched a bold globa...

see more →

Guidelines  1 results

Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657988
MMWR. Morbidity and Mortality Weekly Report; Wong KK, Burdette E et. al.

May 12th, 2017 - Cholera, caused by infection with toxigenic Vibrio cholerae bacteria of serogroup O1 (>99% of global cases) or O139, is characterized by watery diarrhea that can be severe and rapidly fatal without prompt rehydration. Cholera is endemic in approxi...

see more →

Drugs  175 results see all →

Clinicaltrials.gov  42 results

Comparison of Rates of Antimicrobial Use in Febrile Patients With or Without the Use of C-reactive Protein Blood Test
https://clinicaltrials.gov/ct2/show/NCT05292508

Mar 23rd, 2022 - The World Health Organization (WHO) defines antimicrobial resistance (AMR) as a situation where drugs used to treat microbial infection caused by bacteria, viruses, fungi and parasites no longer work to treat infection because of the changes in th...

Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior Change
https://clinicaltrials.gov/ct2/show/NCT04816552

Mar 16th, 2022 - Aim 1. Develop an evidence and theory based WASH mHealth intervention for households in areas with confirmed cholera patients in Dhaka, Bangladesh through formative research Conduct formative research through in-depth interviews, focus group discu...

Preventative Intervention for Cholera for 7 Days
https://clinicaltrials.gov/ct2/show/NCT05166850

Mar 11th, 2022 - This study develops and evaluates a targeted water, sanitation, and hygiene (WASH) intervention to reduce cholera and severe diarrhea among the household members of diarrhea patients in South Kivu, Democratic Republic of the Congo (DRC) through fo...

Cholera-Hospital-Based-Intervention-for-7-days
https://clinicaltrials.gov/ct2/show/NCT04008134

Feb 10th, 2022 - The findings from the recent randomized controlled trial of The Cholera Hospital Based Intervention for 7 Days (CHoBI7) demonstrated that this intervention was effective in significantly reducing symptomatic cholera infections in intervention hous...

Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™ in Nepalese
https://clinicaltrials.gov/ct2/show/NCT04760236

Dec 16th, 2021 - The investigators plan to study immune non-inferiority, safety and lot-to-lot consistency of OCV-S compared to Shanchol™ in 1 to 40 years old healthy Nepalese participants. The investigators hypothesize that the simplified formulation is able to i...

see more →

News  179 results

New Health Crises Emerge in Ukraine as Fighting Continues
https://www.medscape.com/viewarticle/970095

Mar 10th, 2022 - Hypothermia, frostbite, respiratory diseases, mental health issues, and a lack of treatment for heart disease and cancer are the biggest health concerns at the moment for the people of Ukraine, the World Health Organization says. The WHO also is m...

Can Phages Help Where Antibiotics Have Failed?
https://www.medscape.com/viewarticle/969001

Feb 23rd, 2022 - A new film called Salt in My Soul was recently released, with one of the expressed goals being to raise funds for phage research and antibiotic resistance. Mallory Smith The film shares the story of Mallory Smith, a young woman, now deceased, who ...

Meningitis Outbreak Kills 129 in North-East Congo
https://www.medscape.com/viewarticle/958315

Sep 9th, 2021 - KINSHASA (Reuters) - A meningitis outbreak in Democratic Republic of Congo's north-eastern Tshopo province has killed 129 of the 267 people who have been infected since the first cases were discovered in June, the health minister said late on Tues...

FDA Drug Approvals, Pediatrics — 2021 Midyear Review
https://www.medscape.com/viewarticle/956204

Aug 20th, 2021 - Infectious Disease Tembexa (brincidofovir) Brincidofovir is a prodrug of cidofovir. Brincidofovir effectively penetrates cells via its lipid conjugate, releasing the nucleotide analog cidofovir, which then acts to inhibit viral replication. Cidofo...

Edible Cholera Vaccine Promising in Early Trial
https://www.medscape.com/viewarticle/954463

Jul 9th, 2021 - NEW YORK (Reuters Health) - MucoRice-CTB, a cholera toxin B subunit (CTB) vaccine made by grinding up genetically modified grains of rice, showed promise in a proof-of-concept study, researchers say. "Although we have been developing the MucoRice-...

see more →

Patient Education  5 results see all →